The Retinoblastoma Protein - PowerPoint PPT Presentation

1 / 90
About This Presentation
Title:

The Retinoblastoma Protein

Description:

The Retinoblastoma Protein – PowerPoint PPT presentation

Number of Views:829
Avg rating:3.0/5.0
Slides: 91
Provided by: harb4
Category:

less

Transcript and Presenter's Notes

Title: The Retinoblastoma Protein


1
The Retinoblastoma Protein
  • J. William Harbour, MD
  • Washington University, St. Louis

2
Clinical background
  • 1 per 20,000 live births
  • 200 cases per year in the U.S.
  • Most cases present by 2 years old
  • Survival gt95 in developed countries

3
Clinical presentation
  • Leukocoria (80)
  • Strabismus (20)

4
Growth patterns
5
Treatment
6
Clinical genetics
  • Hereditary RB
  • Non-hereditary RB

7
Non-hereditary RB
  • 60 of patients
  • Avg. age at diagnosis 12-24 months
  • Unilateral tumor
  • No second tumor risk

8
Hereditary RB
  • 40 of patients
  • Avg. age at diagnosis 6-12 months

9
Hereditary RB
  • Familial cancer syndrome
  • Bilateral eye tumors
  • Autosomal dominant
  • Second primary tumors
  • Midline intracranial neuroectodermal tumors
  • Osteosarcoma
  • Soft tissue sarcomas
  • Melanomas
  • Epithelial cancers

10
Historical background
11
1951State of RB genetics
12
1971Knudson hypothesis
13
1971Knudson hypothesis
No germline mutation
10-x
10-x
  • Unifocal, unilateral
  • Nonhereditary
  • No second cancers

10x
Germline mutation
10-x
  • Multifocal, bilateral
  • Autosomal dominant
  • Frequent second cancers

10x
14
1980-83RB linked to 13q14
15
1983-86Recessive nature of RB confirmed
16
1985Loss of heterozyosity analysis
  • Cavenee et al., Science 1985

17
1986Cloning of esterase D
18
1986-87Discovery of RB gene
19
Fung et al. 1987
HindIII genomic fragments...
Southern blot...
20
Germline RB gene mutations
  • Mutations present in all(?) RBs
  • No hotspots
  • Most mutations inactivate protein

21
1988RB mutations in other cancers
...but limited spectrum of cancers
22
Early insights into Rb function
23
1987Rb is a nuclear phosphoprotein
24
1988-89 Rb binds to viral oncoproteins
25
1991-92Rb interacts with E2F/DP1 heterodimers
26
1989-92 Role of Rb in cell cycle
  • Rb phosphorylation is cell cycle dependent

27
1990-92Role of Rb in cell cycle
  • Rb is hyperphosphorylated in cycling cells and
    hypophosphorylated in quiescent cells

28
1989-96 Role of Rb in differentiation
  • Rb is hypophosphorylated in differentiated cells

29
1995-96Role of Rb in apoptosis
  • Rb inhibits E2F-induced apoptosis

30
1993Rb inhibits E2F transactivation
31
Model of Rb function early 1990's
  • Rb masks E2F transactivation domain

cell cycle
differentiation
apoposis
32
Model of Rb function early 1990's
  • Rb masks E2F transactivation domain

cell cycle
differentiation
apoposis
cell cycle
differentiation
apoposis
33
1992-95Intrinsic or "active" Rb repressor
activity
...fusion of Rb to DNA binding domains
34
E2F recruits Rb to "actively" repress
transcription
35
1999-2000Active repression regulates G1 arrest
36
How does Rb "actively" repress transcription?
37
How does Rb "actively" repress transcription?
  • Recruitment of chromatin remodeling enzymes to
    E2F-responsive promoters
  • Histone deacetylases
  • SWI/SNF complexes
  • DNA methyltransferases
  • Polycomb complexes
  • Histone methyltransferases

38
1998Rb recruits HDAC
39
2000Rb recruits SWI/SNF complexes
40
2000Rb recruits DNA methyltransferases
41
2001-02Rb recruits Polycomb complexes
42
2001-03Rb recruits histone methylases
...irreversible cell cycle arrest?
43
Rb is involved in a complex array of
multiprotein repressor modules
44
Multiple mechanisms of Rb transcriptional
repression
  • Simple masking of E2F transactivation domain
  • e.g. apoptosis?

45
Multiple mechanisms of Rb transcriptional
repression
  • Reversible active repression
  • e.g. cell cycle

46
Multiple mechanisms of Rb transcriptional
repression
  • Irreversible gene silencing
  • e.g. senescence, differentiation

47
Additional complexity
  • Other pocket proteins
  • p107 p130
  • Multiple E2Fs
  • E2F1-3 bind Rb
  • E2F4 5 bind p107, p130

Stevaux Dyson, 2002
48
Rb protein structure function
49
Rb protein structure
  • 928 amino acids
  • 16 potential CDK phosphorylation sites

Repression
E2F binding
MDM2
LXCXE proteins
c-Abl
50
Rb-E7 crystal structure
  • LXCXE binding site
  • located in B box, which requires interaction with
    A box for active conformation

51
Rb-E2F crystal structure
  • E2F binding site
  • Distinct from LXCXE site
  • Located in cleft at A-B interface
  • Contains residues from both A and B boxes

52
How does phosphorylation regulate Rb?
53
Phosphorylation of Rb
  • 16 potential cdk phosphoacceptor sites

54
Phosphorylation of Rb
  • Rb is phosphorylated by cdk4/6-cyclin D and
    cdk2-cyclin E in G1/S

55
Early model for Rb phosphoregulation
ACTIVE
INACTIVE
56
Early model for Rb phosphoregulation
cdk-cyclins
ACTIVE
INACTIVE
57
Early model for Rb phosphoregulation
cdk-cyclins
ACTIVE
INACTIVE
phosphatases
58
Early model for Rb phosphoregulation
cdk-cyclins
G1
S
ACTIVE
INACTIVE
G1/0
M
phosphatases
59
Problems with simple "on-off" model
  • Why multiple cdk-cyclins?
  • Why don't cells undergo apoptosis during normal
    cell division if E2F is released?
  • Rb-E2F complexes are present beyond G1
  • Difference in phenotype between Rb-/- and p16-/-
    cells

60
p16-Rb pathway
  • p16 requires Rb to inhibit cell growth

61
p16-Rb pathway
  • p16 inhibits cdk4, preventing Rb
    hyperphosphorylation

62
p16-Rb pathway
  • p16 mutated or methylated in many cancers
  • p16 Rb mutations mutually exclusive
  • Suggests linear pathway

63
But the tumor phenotypes are very different
  • Rb-/- tumors
  • High rate of apoptosis
  • Rapid rate of proliferation
  • Sensitivity to chemotherapy
  • p16-/- tumors
  • Low rate of apoptosis
  • Slow rate of proliferation
  • Resistance to chemotherapy

64
Rb phosphorylation is more complex
65
Sites in C-terminus regulate LXCXE binding
c-Abl
TAg
66
Sites in C-terminus regulate LXCXE binding
E2F
67
Progressive phosphorylation of Rb
68
Progressive phosphorylation of Rb
  • Initially, the C-terminus is phosphorylated by
    cdk4-cyclin D
  • This triggers an intramolecular interaction
    between phosphorylated C-terminus and lysine
    patch in the B box
  • This intramolecular alteration displaces HDAC or
    other LXCXE binding proteins

69
Progressive phosphorylation of Rb
  • The C-terminus recruits cdk2-cyclin E to the A-B
    interface, where it can now gain access to
    phosphorylate Ser567
  • This occurs only when cdk2 activity is high
  • Ser567 phosphorylation disrupts A-B interface
    and, consequently, the Rb-E2F interaction

70
Progressive phosphorylation model supported by
crystal structure
71
2003Stepwise Rb phosphorylation in living cells
Cell cycle Differentiation
Apoptosis
72
Model for stepwise phosphorylation and
inactivation of Rb
P
HDAC
P
P
P
Rb
Rb
cdk4
cyclin D
E2F
73
Model for stepwise phosphorylation and
inactivation of Rb
p16
P
HDAC
P
P
P
Rb
Rb
cdk4
cyclin D
E2F
Cell cycle Differentiation
74
Model for stepwise phosphorylation and
inactivation of Rb
p16
P
HDAC
P
P
P
HIGH cdk2
Rb
Rb
cdk4
cyclin D
(or Rb mutation)
E2F
Cell cycle Differentiation
75
Model for stepwise phosphorylation and
inactivation of Rb
Rb Degradation
p16
P
HDAC
P
P
P
P
P
P
HIGH cdk2
P
Rb
Rb
Rb
cdk4
cyclin D
(or Rb mutation)
E2F
567
P
Cell cycle Differentiation
Increased apoptosis
E2F
76
Model for stepwise phosphorylation and
inactivation of Rb
Rb Degradation
p16
P
HDAC
P
P
P
P
P
P
HIGH cdk2
P
Rb
Rb
Rb
cdk4
cyclin D
(or Rb mutation)
E2F
567
P
Cell cycle Differentiation
Increased apoptosis
E2F
Deregulated by p16 inactivation
77
Model for stepwise phosphorylation and
inactivation of Rb
Rb Degradation
p16
P
HDAC
P
P
P
P
P
P
HIGH cdk2
P
Rb
Rb
Rb
cdk4
cyclin D
(or Rb mutation)
E2F
567
P
Cell cycle Differentiation
Increased apoptosis
E2F
Deregulated by p16 inactivation
Deregulated by (complete) Rb inactivation
78
Rb in mouse models
79
Rb/-
  • Pituitary adenomas
  • Medullary thyroid carcinomas
  • No retinoblastomas

80
Rb -/-
  • Die at E12-15
  • Defects in neurogenesis and erythropoeisis
  • Massive apoptosis
  • Lack of differentiation
  • Excessive proliferation
  • No retinal (or other) tumors

81
Partial rescue of Rb-/- phenotype
  • E2F-/-
  • p53-/-
  • Id2-/-

82
Chimeric mice
  • Rb-/- phenotype is largely rescued in chimeric
    mice containing Rb/ cells
  • Pituitary tumors
  • No retinal tumors
  • Many effects of Rb-/- are not cell autonomous
  • Maandag et al., EMBO J 1994 134260

83
Conditional Rb knockout
  • Cre-LoxP system
  • Conditional Rb knockout in CNS PNS
  • Rescue of CNS apoptosis (but not PNS)
  • CNS but not PNS was hypoxic
  • Extra-embryonic effects on phenotype?
  • MacPherson et al., Mol Cell Biol 2003 231044

84
2003Extra-embryonic effects of Rb
  • Do placental changes due to Rb loss account for
    developmental phenotype in Rb-/- mice?

85
2003Extra-embryonic effects of Rb
  • Rb-/- mice supplied normal placenta
  • Tetraploid aggregation
  • Conditional knockout

86
2003Extra-embryonic effects of Rb
  • Normal placenta largely rescued Rb-/- phenotype

87
2003Extra-embryonic effects of Rb
  • Authors' conclusion...

88
Conclusions
  • Rb
  • transcriptional repressor
  • E2F is its major binding partner for access to
    promoters
  • inhibits gene expression temporarily or
    permanently depending on co-repressors
  • HDACs, SWI/SNF, DNA methyltransferases, histone
    methylases, and Polycomb complexes

89
Conclusions
  • Rb
  • part of complex network containing 3 pocket
    proteins and probably at least 8 E2Fs
  • inhibits cell cycle and apoptosis
  • promotes differentiation and senescence

90
Conclusions
  • Rb
  • probably does not play intrinsic role in cell
    cycle regulation
  • temporarily or permanently arrest cells in
    response to internal or external cues as part of
    programs regulating cellular differentiation and
    senescence
Write a Comment
User Comments (0)
About PowerShow.com